Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zirnbauer

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Translational Medicine|July 12, 2025
Differential prognostic roles and clinical implications of mitochondrial and genomic tRNA-derived fragments in colorectal liver metastasesRebecca Zirnbauer, Daphni Ammon, Annalena Renner, et al.
Cancer Letters|December 21, 2025
Spatial organization of stromal subtypes stratifies colorectal cancer patients and predicts clinical outcomesMagdalena Frank, Giulia Ghirardello, James Malcolm Howie, et al.
Gut Microbes|November 22, 2022
Atypical enteropathogenic <i>E. coli</i> are associated with disease activity in ulcerative colitisMaximilian Baumgartner, Rebecca Zirnbauer, Sabine Schlager, et al.
Medcomm|July 8, 2025
Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC TrialRebecca Zirnbauer, Simon Hametner, Jutta Bergler-Klein, et al.
Pediatrics|October 14, 2020
Long-term Outcomes of Individuals With Metabolic Diseases Identified Through Newborn ScreeningUlrike Mütze, Sven F Garbade, Gwendolyn Gramer, et al.
Journal for Immunotherapy of Cancer|November 5, 2024
Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid culturesJulijan Kabiljo, Anna Theophil, Jakob Homola, et al.
JAMA Network Open|August 22, 2025
Dual Immune Checkpoint Inhibition Plus Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Randomized Clinical TrialJohannes Laengle, Irene Kuehrer, Askin Kulu, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Translational Medicine|July 12, 2025
Differential prognostic roles and clinical implications of mitochondrial and genomic tRNA-derived fragments in colorectal liver metastasesRebecca Zirnbauer, Daphni Ammon, Annalena Renner, et al.
Cancer Letters|December 21, 2025
Spatial organization of stromal subtypes stratifies colorectal cancer patients and predicts clinical outcomesMagdalena Frank, Giulia Ghirardello, James Malcolm Howie, et al.
Gut Microbes|November 22, 2022
Atypical enteropathogenic <i>E. coli</i> are associated with disease activity in ulcerative colitisMaximilian Baumgartner, Rebecca Zirnbauer, Sabine Schlager, et al.
Medcomm|July 8, 2025
Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC TrialRebecca Zirnbauer, Simon Hametner, Jutta Bergler-Klein, et al.
Pediatrics|October 14, 2020
Long-term Outcomes of Individuals With Metabolic Diseases Identified Through Newborn ScreeningUlrike Mütze, Sven F Garbade, Gwendolyn Gramer, et al.
Journal for Immunotherapy of Cancer|November 5, 2024
Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid culturesJulijan Kabiljo, Anna Theophil, Jakob Homola, et al.
JAMA Network Open|August 22, 2025
Dual Immune Checkpoint Inhibition Plus Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Randomized Clinical TrialJohannes Laengle, Irene Kuehrer, Askin Kulu, et al.
Pageof 3